Proprietary principal investments in AI, deeptech, life sciences, and defence-tech across the US, UK, and India — backed by over a decade of cross-border investment experience.
We invest with conviction in technologies shaping the next decade — where deep scientific expertise creates durable competitive advantage, and cross-border market access compounds value over time.
Foundation models, applied AI infrastructure, and enterprise intelligence tools — with a focus on strong technical differentiation and cross-border scalability.
Quantum computing, advanced materials, semiconductors, biotech, and medtech — where science creates moats that compound over long horizons.
Autonomous systems, national security technology, and dual-use deeptech with commercial and government applications across allied markets.
Companies built to scale across the US, UK, and India from day one — with structural advantages in multi-jurisdiction capital and distribution.
Backing founders who understand the science deeply — not just the market narrative. Technical moats compound over time and are far harder to replicate than business model innovation.
Preference for companies building with cross-border market access in mind from inception — particularly the US–India and UK–India corridors, where our network is deepest.
Pre-seed to Series A — where pricing is still fair and the right operator-investor relationship creates real value beyond capital. We back founders before the crowd arrives.
Frontier technology compounds slowly. We invest with 7–10 year horizons and back founders through the full arc of company building — not just the fundraising milestones.
Eleven companies backed through Fund I across life sciences, fintech, deeptech, AI, and consumer technology in the US and UK. Hover to pause.